Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 16
Review
Tildrakizumab: An Evidence-Based Review of Its Use in the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,872 | Dovepress* | 5,791+ | 940 | 6,731 | |
| PubMed Central* | 2,081 | 337 | 2,418 | ||
| Totals | 7,872 | 1,277 | 9,149 | ||
| *Since 24 September 2020 | |||||
View citations on PubMed and Google Scholar